SPRY
Price
$14.00
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
34 days until earnings call
TARS
Price
$32.27
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
33 days until earnings call
Ad is loading...

SPRY vs TARS

Header iconSPRY vs TARS Comparison
Open Charts SPRY vs TARSBanner chart's image
ARS Pharmaceuticals
Price$14.00
Change-$0.00 (-0.00%)
Volume$837.89K
CapitalizationN/A
Tarsus Pharmaceuticals
Price$32.27
Change-$0.00 (-0.00%)
Volume$300.93K
CapitalizationN/A
View a ticker or compare two or three
SPRY vs TARS Comparison Chart
Loading...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
SPRY vs. TARS commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPRY is a StrongBuy and TARS is a Hold.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (SPRY: $14.00 vs. TARS: $32.27)
Brand notoriety: SPRY and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPRY: 67% vs. TARS: 44%
Market capitalization -- SPRY: $1.39B vs. TARS: $1.25B
SPRY [@Biotechnology] is valued at $1.39B. TARS’s [@Biotechnology] market capitalization is $1.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPRY’s FA Score shows that 0 FA rating(s) are green whileTARS’s FA Score has 0 green FA rating(s).

  • SPRY’s FA Score: 0 green, 5 red.
  • TARS’s FA Score: 0 green, 5 red.
According to our system of comparison, TARS is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPRY’s TA Score shows that 1 TA indicator(s) are bullish while TARS’s TA Score has 4 bullish TA indicator(s).

  • SPRY’s TA Score: 1 bullish, 6 bearish.
  • TARS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TARS is a better buy in the short-term than SPRY.

Price Growth

SPRY (@Biotechnology) experienced а -3.51% price change this week, while TARS (@Biotechnology) price change was -2.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

SPRY is expected to report earnings on Nov 07, 2024.

TARS is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.39B) has a higher market cap than TARS($1.25B). SPRY YTD gains are higher at: 155.474 vs. TARS (59.358). SPRY has higher annual earnings (EBITDA): -56.74M vs. TARS (-144.23M). TARS has more cash in the bank: 324M vs. SPRY (219M). SPRY has less debt than TARS: SPRY (160K) vs TARS (72.2M). TARS has higher revenues than SPRY: TARS (83.4M) vs SPRY (500K).
SPRYTARSSPRY / TARS
Capitalization1.39B1.25B111%
EBITDA-56.74M-144.23M39%
Gain YTD155.47459.358262%
P/E RatioN/AN/A-
Revenue500K83.4M1%
Total Cash219M324M68%
Total Debt160K72.2M0%
TECHNICAL ANALYSIS
Technical Analysis
SPRYTARS
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFCVX21.73-0.06
-0.28%
Hennessy Cornerstone Value Investor
TQCYX19.29-0.07
-0.36%
Touchstone Dividend Equity Y
IHGIX37.00-0.19
-0.51%
Hartford Dividend and Growth A
NGCAX38.14-0.23
-0.60%
Columbia Greater China A
WBSRX36.67-0.29
-0.78%
William Blair Small Cap Growth R6

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-3.11%
LPCN - SPRY
63%
Loosely correlated
+5.41%
INZY - SPRY
45%
Loosely correlated
+0.60%
ACLX - SPRY
42%
Loosely correlated
-0.04%
VIR - SPRY
41%
Loosely correlated
-4.56%
STRO - SPRY
39%
Loosely correlated
+0.57%
More